Appointment booking for Dr. Susheer Gandotra, MD is currently not available.Dr. Susheer Gandotra, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Susheer Gandotra, MD (he/him) is a Infectious Disease Doctor in East Stroudsburg, PA with over 18 years of experience. What is your opinion of Dr. Susheer Gandotra, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Susheer Gandotra, MD has received over $1,821 which includes payments from the following companies:
$328.67 from Allergan Inc.
$240.06 from E.R. Squibb & Sons, L.L.C.
$200.00 from COMSORT, Inc
$167.82 from Astellas Pharma US Inc
$124.61 from Janssen Biotech, Inc.
$116.31 from Durata Therapeutics Inc.
$99.95 from Janssen Products, LP
$94.01 from ViiV Healthcare Company
$93.37 from Pfizer Inc.
$77.71 from Janssen Pharmaceuticals, Inc
$61.36 from Gilead Sciences Inc
$61.02 from Merck Sharp & Dohme Corporation
$52.96 from The Medicines Company
$25.85 from AbbVie, Inc.
$25.82 from sanofi-aventis U.S. LLC
$14.17 from Oxford Immunotec Inc.
$13.61 from Sanofi Pasteur Inc.
$13.08 from Bioventus LLC
$10.88 from Salix Pharmaceuticals, Ltd
Payments received by Dr. Susheer Gandotra, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!